Literature DB >> 10704361

Positive and negative regulation of TGF-beta signaling.

K Miyazono1.   

Abstract

Cytokines of the transforming growth factor beta (TGF-beta) superfamily, including TGF-betas, activins and bone morphogenetic proteins (BMPs), bind to specific serine/threonine kinase receptors and transmit intracellular signals through Smad proteins. Upon ligand stimulation, Smads move into the nucleus and function as components of transcription complexes. TGF-beta and BMP signaling is regulated positively and negatively through various mechanisms. Positive regulation amplifies signals to a level sufficient for biological activity. Negative regulation occurs at the extracellular, membrane, cytoplasmic and nuclear levels. TGF-beta and BMP signaling is often regulated through negative feedback mechanisms, which limit the magnitude of signals and terminate signaling. Negative regulation is also important for formation of gradients of morphogens, which is crucial in developmental processes. In addition, other signaling pathways regulate TGF-beta and BMP signaling through cross-talk. Nearly 20 BMP isoforms have been identified, and their activities are regulated by various extracellular antagonists. Regulation of TGF-beta signaling might be tightly linked to tumor progression, since TGF-beta is a potent growth inhibitor in most cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704361     DOI: 10.1242/jcs.113.7.1101

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  85 in total

1.  Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins.

Authors:  M Fukuchi; T Imamura; T Chiba; T Ebisawa; M Kawabata; K Tanaka; K Miyazono
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  [Renal osteopathy--an extra-orthopedic zone?].

Authors:  C Wittig
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

3.  ZAS3 accentuates transforming growth factor β signaling in epithelial cells.

Authors:  Adam J Yakovich; Bo Jiang; Carl E Allen; Jianguo Du; Lai-Chu Wu; John A Barnard
Journal:  Cell Signal       Date:  2010-08-21       Impact factor: 4.315

Review 4.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

5.  Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.

Authors:  Myoungkun Jeoung; Eun Ryoung Jang; Jinpeng Liu; Chi Wang; Eric C Rouchka; Xiaohong Li; Emilia Galperin
Journal:  Cell Signal       Date:  2016-02-11       Impact factor: 4.315

6.  Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.

Authors:  Ashley M Lakner; Nury M Steuerwald; Tracy L Walling; Sriparna Ghosh; Ting Li; Iain H McKillop; Mark W Russo; Herbert L Bonkovsky; Laura W Schrum
Journal:  Hepatology       Date:  2012-06-18       Impact factor: 17.425

7.  SMAD4 protein expression and cell proliferation in colorectal adenocarcinomas.

Authors:  Adriana Handra-Luca; Sylviane Olschwang; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2011-10-16       Impact factor: 4.064

8.  Computational modelling of Smad-mediated negative feedback and crosstalk in the TGF-β superfamily network.

Authors:  Daniel Nicklas; Leonor Saiz
Journal:  J R Soc Interface       Date:  2013-06-26       Impact factor: 4.118

Review 9.  Vaccine and immune cell therapy in non-small cell lung cancer.

Authors:  Helena Oliveres; Christian Caglevic; Francesco Passiglia; Simona Taverna; Evelien Smits; Christian Rolfo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

10.  Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.

Authors:  Daizo Koinuma; Masahiko Shinozaki; Akiyoshi Komuro; Kouichiro Goto; Masao Saitoh; Aki Hanyu; Masahito Ebina; Toshihiro Nukiwa; Keiji Miyazawa; Takeshi Imamura; Kohei Miyazono
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.